tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

GLUE Stock Latest News

Monte Rosa Therapeutics initiated with an Outperform at LifeSci Capital
The FlyMonte Rosa Therapeutics initiated with an Outperform at LifeSci Capital
7h ago
GLUE
Monte Rosa Therapeutics Outlines 2025 Milestones and Financial Strength
PremiumCompany Announcements
Monte Rosa Therapeutics Outlines 2025 Milestones and Financial Strength
2M ago
8K
GLUE
Monte Rosa Therapeutics provide corporate update, key milestones 2025
PremiumThe Fly
Monte Rosa Therapeutics provide corporate update, key milestones 2025
2M ago
GLUE
Monte Rosa downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe Fly
Monte Rosa downgraded to Equal Weight from Overweight at Wells Fargo
3M ago
GLUE
Monte Rosa Therapeutics appoints Hughes to board of directors
PremiumThe Fly
Monte Rosa Therapeutics appoints Hughes to board of directors
3M ago
GLUE
TEVA
Monte Rosa announces closing of global license agreement with Novartis
PremiumThe FlyMonte Rosa announces closing of global license agreement with Novartis
3M ago
NVS
GLUE
Monte Rosa Therapeutics presents preclinical data on CDK2 degrader
Premium
The Fly
Monte Rosa Therapeutics presents preclinical data on CDK2 degrader
3M ago
GLUE
Monte Rosa Highlights Promising Results in Cancer Study
Premium
Company Announcements
Monte Rosa Highlights Promising Results in Cancer Study
3M ago
8K
GLUE
Monte Rosa Therapeutics provides development progress on ongoing MRT-2359 study
PremiumThe Fly
Monte Rosa Therapeutics provides development progress on ongoing MRT-2359 study
3M ago
GLUE
Monte Rosa Therapeutics Expands Pipeline with Novartis Deal
PremiumCompany Announcements
Monte Rosa Therapeutics Expands Pipeline with Novartis Deal
4M ago
GLUE
Monte Rosa Therapeutics reports Q3 EPS (29c), consensus (49c)
PremiumThe Fly
Monte Rosa Therapeutics reports Q3 EPS (29c), consensus (49c)
4M ago
GLUE
Boeing to offer 90M common shares, Philips reports mixed Q3: Morning Buzz
PremiumThe Fly
Boeing to offer 90M common shares, Philips reports mixed Q3: Morning Buzz
5M ago
BA
ON
Monte Rosa Therapeutics price target raised to $20 from $16 at Piper Sandler
PremiumThe FlyMonte Rosa Therapeutics price target raised to $20 from $16 at Piper Sandler
5M ago
NVS
GLUE
Monte Rosa Enters Global License Agreement with Novartis
Premium
Company Announcements
Monte Rosa Enters Global License Agreement with Novartis
5M ago
8K
GLUE
Monte Rosa announces global license agreement with Novartis
Premium
The Fly
Monte Rosa announces global license agreement with Novartis
5M ago
NVS
GLUE
Monte Rosa Therapeutics presents preclinical data at ENA 2024
PremiumThe Fly
Monte Rosa Therapeutics presents preclinical data at ENA 2024
5M ago
GLUE
Monte Rosa Therapeutics announces first participants dosed in MRT-6160 study
PremiumThe Fly
Monte Rosa Therapeutics announces first participants dosed in MRT-6160 study
7M ago
GLUE
Monte Rosa Therapeutics price target lowered to $17 from $18 at Wells Fargo
PremiumThe Fly
Monte Rosa Therapeutics price target lowered to $17 from $18 at Wells Fargo
7M ago
GLUE
Monte Rosa Therapeutics sees cash runway into 1H27
PremiumThe Fly
Monte Rosa Therapeutics sees cash runway into 1H27
7M ago
GLUE
Monte Rosa Therapeutics achieves milestones under Roche collaboration agreement
PremiumThe FlyMonte Rosa Therapeutics achieves milestones under Roche collaboration agreement
7M ago
GLUE
Monte Rosa Therapeutics announces FDA acceptance of IND for MRT-6160
Premium
The Fly
Monte Rosa Therapeutics announces FDA acceptance of IND for MRT-6160
7M ago
GLUE
Monte Rosa Therapeutics reports Q2 EPS (43c), consensus (54c)
Premium
The Fly
Monte Rosa Therapeutics reports Q2 EPS (43c), consensus (54c)
7M ago
GLUE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >